跳至主要内容
临床试验/NCT02742987
NCT02742987已完成4 期

CLOpidogrel Versus TIcagreLor for Antiplatelet Maintenance in DIAbetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study

Campus Bio-Medico University0 个研究点目标入组 42 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
42
主要终点
Flow-mediated Dilation of the Brachial Artery

研究概览

简要总结

CLOTILDIA is a single-center, prospective, randomized, open label, cross-over study evaluating the effects of ticagrelor versus high-dose clopidogrel on endothelial function and platelet reactivity in patients with type-2 diabetes mellitus (T2DM) treated with percutaneous coronary intervention (PCI).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • type 2 diabetes mellitus
  • stable coronary disease
  • coronary revascularization with PCI at least 1 month prior to recruitment

排除标准

  • acute coronary syndrome
  • platelet count <70x109/l
  • active bleeding or bleeding diathesis
  • history of intracranial bleeding
  • gastrointestinal bleeding <6 months
  • cerebrovascular accident <3 months
  • history of malignancy
  • concomitant need for oral anticoagulant therapy
  • severe liver disease or chronic renal failure (glomerular filtration rate <30 ml/min /1.73m2)

研究组 & 干预措施

Ticagrelor group

Experimental

Ticagrelor 90 mg twice daily + standard medical therapy

干预措施: Ticagrelor (Drug)

Ticagrelor group

Experimental

Ticagrelor 90 mg twice daily + standard medical therapy

干预措施: Standard medical therapy (Drug)

Clopidogrel group

Experimental

Clopidogrel 150 mg once daily + standard medical therapy

干预措施: Clopidogrel (Drug)

Clopidogrel group

Experimental

Clopidogrel 150 mg once daily + standard medical therapy

干预措施: Standard medical therapy (Drug)

结局指标

主要结局

Flow-mediated Dilation of the Brachial Artery

时间窗: 4 weeks

Percent dilation of the brachial artery, as assessed with vascular ultrasound, from baseline to post-occlusion

次要结局

  • Platelet Reactivity(4 weeks)
  • Endothelium-independent Dilation of the Brachial Artery(4 weeks)
  • Number of Patients With Flow-mediated Dilation of the Brachial Artery <7%(4 weeks)
  • Number of Patients With Platelet Reactivity >256 P2Y12 Reaction Units(4 weeks)

研究者

发起方
Campus Bio-Medico University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Germano Di Sciascio

Prof. Germano Di Sciascio

Campus Bio-Medico University

相似试验